Pharmacogenomics

Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populations
pp. 489-492(4)
Authors: Zhang, Wei; Dolan, M Eileen

Future of individualized psychiatric treatment
pp. 493-495(3)
Authors: Campbell, Daniel B; Levitt, Pat

Association between genetic variant and susceptibility to nicotine dependence found
pp. 497-499(3)

Serotonin type 3 receptor genes: HTR3A, B, C, D, E
pp. 501-504(4)
Authors: Niesler, Beate; Kapeller, Johannes; Hammer, Christian; Rappold, Gudrun

Pharmacogenetic response to albuterol among asthmatics
pp. 505-510(6)
Authors: Corvol, Harriet; Burchard, Esteban González

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans
pp. 511-526(16)
Authors: Limdi, Nita A; Arnett, Donna K; Goldstein, Joyce A; Beasley, T Mark; McGwin, Gerald; Adler, Brian K; Acton, Ronald T

Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy
pp. 527-537(11)
Authors: Seo, Takayuki; Nagata, Rie; Ishitsu, Takateru; Murata, Tsukasa; Takaishi, Chisato; Hori, Masaharu; Nakagawa, Kazuko

Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer
pp. 539-549(11)
Authors: Obradovic, Marko; Mrhar, Ales; Kos, Mitja

CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians
pp. 551-560(10)
Authors: Soya, S S; Vinod, T; Reddy, K S; Gopalakrishnan, S; Adithan, C

Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents
pp. 561-584(24)
Authors: Meletiadis, Joseph; Chanock, Stephen; Walsh, Thomas J

Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients
pp. 585-596(12)
Authors: Ekbal, Nasirul J; Holt, David W; MacPhee, Iain AM

Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney
pp. 597-624(28)
Authors: Zaïr, Zoulikha M; Eloranta, Jyrki J; Stieger, Bruno; Kullak-Ublick, Gerd A

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
pp. 625-637(13)
Authors: Gunes, Arzu; Dahl, Marja-Liisa

Pharmacogenomics of the response to IFN-β in multiple sclerosis: ramifications from the first genome-wide screen
pp. 639-645(7)
Authors: Vandenbroeck, Koen; Matute, Carlos

Acknowledgements
pp. 653-653(1)